Revolution Medicines, Inc. Shares Outstanding (Cover Page)
Revolution Medicines, Inc. (RVMD) had Shares Outstanding (Cover Page) of 214.34 million shares as of 2026-07-31, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-05
- 2026-07-31: Entity Common Stock, Shares Outstanding 214.34M shares.
- 2026-05-01: Entity Common Stock, Shares Outstanding 212.60M shares.
- 2026-02-20: Entity Common Stock, Shares Outstanding 198.17M shares.
- 2025-10-31: Entity Common Stock, Shares Outstanding 193.32M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-07-31 | 214.34M shares 10-Q · filed 2026-08-05 |
| 2026-05-01 | 212.60M shares 10-Q · filed 2026-05-06 |
| 2026-02-20 | 198.17M shares 10-K · filed 2026-02-25 |
| 2025-10-31 | 193.32M shares 10-Q · filed 2025-11-05 |
| 2025-08-01 | 186.93M shares 10-Q · filed 2025-08-06 |
| 2025-05-02 | 186.27M shares 10-Q · filed 2025-05-07 |
| 2025-02-21 | 185.91M shares 10-K · filed 2025-02-26 |
| 2024-11-04 | 168.22M shares 10-Q · filed 2024-11-06 |
| 2024-08-02 | 167.04M shares 10-Q · filed 2024-08-07 |
| 2024-05-02 | 164.99M shares 10-Q · filed 2024-05-08 |
| 2024-02-21 | 164.69M shares 10-K · filed 2024-02-26 |
| 2023-11-01 | 109.56M shares 10-Q · filed 2023-11-06 |
| 2023-08-03 | 109.17M shares 10-Q · filed 2023-08-08 |
| 2023-05-04 | 106.31M shares 10-Q · filed 2023-05-08 |
| 2023-02-23 | 90.49M shares 10-K · filed 2023-02-27 |
| 2022-11-02 | 88.79M shares 10-Q · filed 2022-11-07 |
| 2022-08-04 | 87.70M shares 10-Q · filed 2022-08-09 |
| 2022-05-04 | 74.25M shares 10-Q · filed 2022-05-09 |
| 2022-02-23 | 74.19M shares 10-K · filed 2022-02-28 |
| 2021-11-04 | 73.69M shares 10-Q · filed 2021-11-10 |
| 2021-08-06 | 73.58M shares 10-Q · filed 2021-08-11 |
| 2021-05-05 | 73.44M shares 10-Q · filed 2021-05-10 |
| 2021-02-24 | 73.38M shares 10-K · filed 2021-03-02 |
| 2020-11-09 | 66.38M shares 10-Q · filed 2020-11-12 |
| 2020-08-05 | 65.93M shares 10-Q · filed 2020-08-10 |
| 2020-05-08 | 59.01M shares 10-Q · filed 2020-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |